Headlines about Owens & Minor (NYSE:OMI) have trended somewhat positive on Saturday, according to Accern. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Owens & Minor earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.4019281966601 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
These are some of the headlines that may have effected Accern’s rankings:
- Owens & Minor Has Returned 18.6% Since SmarTrend Recommendation (OMI) (mysmartrend.com)
- Top Ranked Income Stocks to Buy for August 14th (finance.yahoo.com)
- Head to Head Contrast: Merit Medical Systems (MMSI) and Owens & Minor (OMI) (americanbankingnews.com)
- See what the IHS Markit Score report has to say about Owens & Minor Inc. (finance.yahoo.com)
OMI has been the subject of a number of analyst reports. Zacks Investment Research downgraded shares of Owens & Minor from a “hold” rating to a “sell” rating in a research note on Friday, May 5th. TheStreet downgraded shares of Owens & Minor from a “b” rating to a “c+” rating in a research note on Thursday, May 4th. BidaskClub downgraded shares of Owens & Minor from a “hold” rating to a “sell” rating in a research note on Tuesday, June 20th. Jefferies Group LLC set a $36.00 target price on shares of Owens & Minor and gave the company a “hold” rating in a research note on Monday, May 22nd. Finally, UBS AG reaffirmed a “sell” rating and set a $29.50 target price (down previously from $30.50) on shares of Owens & Minor in a research note on Thursday, August 3rd. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $31.88.
Shares of Owens & Minor (OMI) opened at 27.60 on Friday. The company’s 50 day moving average is $30.65 and its 200 day moving average is $33.09. Owens & Minor has a 12 month low of $27.23 and a 12 month high of $37.02. The company has a market cap of $1.69 billion, a P/E ratio of 17.56 and a beta of 1.01.
Owens & Minor (NYSE:OMI) last posted its quarterly earnings data on Tuesday, August 1st. The company reported $0.43 EPS for the quarter, hitting the consensus estimate of $0.43. The firm had revenue of $2.27 billion during the quarter, compared to analyst estimates of $2.38 billion. Owens & Minor had a net margin of 1.02% and a return on equity of 11.64%. Owens & Minor’s revenue was down 8.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.52 EPS. On average, equities research analysts predict that Owens & Minor will post $1.92 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be paid a dividend of $0.2575 per share. The ex-dividend date is Thursday, September 14th. This represents a $1.03 annualized dividend and a dividend yield of 3.73%. Owens & Minor’s dividend payout ratio (DPR) is presently 65.19%.
In related news, SVP Erika T. Davis sold 9,317 shares of the business’s stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $32.26, for a total transaction of $300,566.42. Following the completion of the transaction, the senior vice president now owns 63,979 shares in the company, valued at approximately $2,063,962.54. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Rony Camil Kordahi sold 2,231 shares of the business’s stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $32.07, for a total transaction of $71,548.17. Following the transaction, the executive vice president now owns 27,555 shares of the company’s stock, valued at approximately $883,688.85. The disclosure for this sale can be found here. Insiders own 1.68% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Owens & Minor (NYSE:OMI) Getting Somewhat Favorable News Coverage, Accern Reports” was published by BNB Daily and is owned by of BNB Daily. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.baseball-news-blog.com/2017/08/19/owens-minor-nyseomi-earns-daily-media-impact-score-of-0-16-updated-updated.html.
Owens & Minor Company Profile
Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).
Receive News & Ratings for Owens & Minor Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor Inc. and related companies with MarketBeat.com's FREE daily email newsletter.